NCT01512004View on ClinicalTrials.gov

Propiverine Hydrochloride Extended-Release Capsule for Overactive Bladder

PHASE3CompletedINTERVENTIONAL
Enrollment

324

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

January 31, 2010

Study Completion Date

August 31, 2011

Conditions
Overactive Bladder
Interventions
DRUG

Propiverine Hydrochloride

drug of oral capsule

DRUG

Tolterodine Extended-release Tablet

4mg/tablet; oral; once per day

Trial Locations (1)

Unknown

Beijing Chaoyang Hospital, Beijing

Sponsors
All Listed Sponsors
collaborator

APOGEPHA Arzneimittel GmbH

INDUSTRY

lead

Lee's Pharmaceutical Limited

INDUSTRY